Faculty profile

Mohammad-Ali Jenabian

ResearcherUniversité de Montréal

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses and email address may be missing. Find their university profile.

Mohammad-Ali Jenabian

Researcher

Health Sciences

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
28 publications in the last five years, latest in 2026.
Senior (last) author on 10 recent papers, a sign of leading a research group.
Principal investigator on 2 research grants (2 CIHR), most recently in 2018.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Cardiovascular Frailty Hiv Aging Cardiovascular Imaging Hiv Reservoirs Immune Activation Sex Ang Gender

Latest papers

Gut-heart immuno-metabolic disruption associated with inflammaging and subclinical coronary artery disease in people with HIV on antiretroviral therapy.
Immunity & ageing : I & A · 2026 · senior author
Impact of Oral Cannabinoids on the Endocannabinoidome and Gut Microbiome in People with HIV on Antiretroviral Therapy (CTN PT028 Pilot Clinical Trial).
Cannabis and cannabinoid research · 2026
Knowledge of Cannabinoid Content Among People Living with HIV Who Use Cannabis: a Daily Diary Study.
International journal of behavioral medicine · 2025

All 77 publications

Latest funding

Building Capacity in Innovative Adaptive Trial Designs for HIV and STBBI Research: The CTN-Québec Training Platform
CIHR · 2025 · Co-investigator
$800,000
Aging with HIV: understanding heterogeneity to promote health for all
CIHR · 2024 · Co-investigator
$19,690
Canadian HIV Cure Enterprise 3.0: Targeting tissue HIV reservoirs
CIHR · 2024 · Co-investigator
$3,750,000

All 6 grants and awards

77 publications.

Gut-heart immuno-metabolic disruption associated with inflammaging and subclinical coronary artery disease in people with HIV on antiretroviral therapy.

Diego-Matos AK, Frias Boligan K, Mboumba Bouassa RS, Durand M, Tremblay C, Chartrand-Lefebvre C, El-Far M, Messier-Peet M, Giffard-Bouvier J, Margolese S, Ancuta P, Kema I, Costiniuk CT, Jenabian MA

Immunity & ageing : I & A2026Senior author

DOI: 10.1186/s12979-026-00566-8 PMID: 42046076

Impact of Oral Cannabinoids on the Endocannabinoidome and Gut Microbiome in People with HIV on Antiretroviral Therapy (CTN PT028 Pilot Clinical Trial).

Giorgini G, Silvestri C, Mboumba Bouassa RS, Muller C, Frias Boligan K, Kalkan H, Routy JP, Flamand N, Di Marzo V, Jenabian MA, Costiniuk CT

Cannabis and cannabinoid research2026

DOI: 10.1177/25785125251366052 PMID: 40879543

Knowledge of Cannabinoid Content Among People Living with HIV Who Use Cannabis: a Daily Diary Study.

Coelho SG, Rueda S, Costiniuk CT, Jenabian MA, Margolese S, Mandarino E, Shuper PA, Hendershot CS, Cunningham JA, Arbess G, Singer J, Wardell JD

International journal of behavioral medicine2025

DOI: 10.1007/s12529-023-10221-x PMID: 37794278

Double-Negative T-Cells during Acute Human Immunodeficiency Virus and Simian Immunodeficiency Virus Infections and Following Early Antiretroviral Therapy Initiation.

Yero A, Shi T, Clain JA, Zghidi-Abouzid O, Racine G, Costiniuk CT, Routy JP, Estaquier J, Jenabian MA

Viruses2024Senior author

DOI: 10.3390/v16101609 PMID: 39459942

Altered memory CCR6+ Th17-polarised T-cell function and biology in people with HIV under successful antiretroviral therapy and HIV elite controllers.

Yero A, Goulet JP, Shi T, Costiniuk CT, Routy JP, Tremblay C, Mboumba Bouassa RS, Alexandrova Y, Pagliuzza A, Chomont N, Ancuta P, Jenabian MA

EBioMedicine2024Senior author

DOI: 10.1016/j.ebiom.2024.105274 PMID: 39178742

Plasma endocannabinoidome and fecal microbiota interplay in people with HIV and subclinical coronary artery disease: Results from the Canadian HIV and Aging Cohort Study.

Mboumba Bouassa RS, Giorgini G, Silvestri C, Muller C, Nallabelli N, Alexandrova Y, Durand M, Tremblay C, El-Far M, Chartrand-Lefebvre C, Messier-Peet M, Margolese S, Flamand N, Costiniuk CT, Di Marzo V, Jenabian MA

iScience2024Senior author

DOI: 10.1016/j.isci.2024.110456 PMID: 39156649

Feasibility of a Randomized, Interventional Pilot Clinical Study of Oral Cannabinoids in People with HIV on Antiretroviral Therapy: CTNPT 028.

Mboumba Bouassa RS, Needham J, Nohynek D, Samarani S, Bobeuf F, Del Balso L, Paisible N, Vertzagias C, Sebastiani G, Margolese S, Mandarino E, Singer J, Klein M, Lebouché B, Cox J, Vulesevic B, Müller A, Lau E, Routy JP, Jenabian MA, Costiniuk CT

Journal of personalized medicine2024

DOI: 10.3390/jpm14070745 PMID: 39063999

Dynamics of pulmonary mucosal cytotoxic CD8 T-cells in people living with HIV under suppressive antiretroviral therapy.

Alexandrova Y, Yero A, Olivenstein R, Orlova M, Schurr E, Estaquier J, Costiniuk CT, Jenabian MA

Respiratory research2024Senior author

DOI: 10.1186/s12931-024-02859-2 PMID: 38867225

Efficient enzyme-free method to assess the development and maturation of the innate and adaptive immune systems in the mouse colon.

Lassoued N, Yero A, Jenabian MA, Soret R, Pilon N

Scientific reports2024

DOI: 10.1038/s41598-024-61834-5 PMID: 38744932

Correlates of Breakthrough SARS-CoV-2 Infections in People with HIV: Results from the CIHR CTN 328 Study.

Costiniuk CT, Lee T, Singer J, Galipeau Y, Arnold C, Langlois MA, Needham J, Jenabian MA, Burchell AN, Samji H, Chambers C, Walmsley S, Ostrowski M, Kovacs C, Tan DHS, Harris M, Hull M, Brumme ZL, Lapointe HR, Brockman MA, Margolese S, Mandarino E, Samarani S, Lebouché B, Angel JB, Routy JP, Cooper CL, Anis AH, COVAXHIV Study Group

Vaccines2024

DOI: 10.3390/vaccines12050447 PMID: 38793698

Building Capacity in Innovative Adaptive Trial Designs for HIV and STBBI Research: The CTN-Québec Training Platform

Co-investigatorCIHR2025HIV/AIDS & STBBI Clinical Trials Research Network - Phase 2

Principal investigators: Durand, Madeleine; Beaudry, Sylvain; Fontaine, Guillaume; Gilbert, Caroline; Golchi, Shirin; Greenstreet, Peter J; Hedrich, Tanguy; Lebouché, Bertrand; Lessard, David; Vicente, Sergio

Keywords: Adaptive Trials; Hiv; Implementation Science; Stbbi; Training

$800,000

Aging with HIV: understanding heterogeneity to promote health for all

Co-investigatorCIHR2024T. Gr.: Embracing Diversity -HIV/AIDS/STBBI-Co-infections and Co-morbidities-LOI

Principal investigators: Durand, Madeleine; Monteith, Kenneth M; Chartrand-Lefebvre, Carl; Murzin, Kate

Keywords: Aging; Comorbidity; Gender; Hiv; Inflammation; People Who Use Drugs

$19,690

Canadian HIV Cure Enterprise 3.0: Targeting tissue HIV reservoirs

Co-investigatorCIHR2024TG: Biomedical Res. for HIV/AIDS/STBBI-Next-Gen.Therapeutic Interv.-Large Team

Principal investigators: Chomont, Nicolas; Margolese, Shari L; Ancuta, Petronela; Angel, Jonathan B; Cohen, Eric A; Costiniuk, Cecilia T; Murooka, Thomas T

Keywords: Cd4 T Cells; Hiv Cure; Hiv Immunity; Hiv Persistence; Hiv Reservoir; Human Studies; Humanized Mouse Models; Myeloid Cells; Therapeutic Interventions; Tissue

$3,750,000

Discovering pathways to successful aging in HIV infection

Principal investigatorCIHR2018Team Grant - HIV/AIDS Comorbidities Prevention and Healthy Living

Principal investigators: Durand, Madeleine; Margolese, Shari L; Bernard, Nicole F; Chartrand-Lefebvre, Carl; Chomont, Nicolas; Jenabian, Mohammad-Ali; Mansour, Samer; Tremblay, Cécile L; Tsoukas, Christos M

Keywords: Aging; Cardiovascular; Cardiovascular Imaging; Frailty; Hiv; Hiv Reservoirs; Immune Activation; Sex Ang Gender

$2,476,710

Canadian HIV Cure Enterprise 2.0: Targeting the interplay between myeloid cells and CD4+ T-cells for HIV cure

Co-investigatorCIHR2018Team Grant: HIV/AIDS Biomedical and Clinical Research - Cure - Large

Principal investigators: Cohen, Eric A; Margolese, Shari L; Rosenes, Ron; Ancuta, Petronela; Angel, Jonathan B; Chomont, Nicolas; Estaquier, Jérôme; Murooka, Thomas T; Routy, Jean-Pierre

Keywords: Hiv Cure; Hiv Latency; Hiv Persistence; Hiv Reservoirs; Human Studies; Humanized Mouse Models; Memory Cd4+ T-Cells; Myeloid Cells; Non-Human Primate Model; Therapeutic Interventions

$6,000,000

Discovering immune pathways to successful aging in HIV infection

Principal investigatorCIHR2017Team Grant: HIV/AIDS Comorbidities Prevention and Healthy Living - LOI

Keywords: Cardiovascular; Cohort Study; Frailty; Hiv; Immunology; Viral Reservoirs

$25,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Mohammad-Ali Jenabian

Research

Latest papers

Latest funding

Gut-heart immuno-metabolic disruption associated with inflammaging and subclinical coronary artery disease in people with HIV on antiretroviral therapy.

Impact of Oral Cannabinoids on the Endocannabinoidome and Gut Microbiome in People with HIV on Antiretroviral Therapy (CTN PT028 Pilot Clinical Trial).

Knowledge of Cannabinoid Content Among People Living with HIV Who Use Cannabis: a Daily Diary Study.

Double-Negative T-Cells during Acute Human Immunodeficiency Virus and Simian Immunodeficiency Virus Infections and Following Early Antiretroviral Therapy Initiation.

Altered memory CCR6+ Th17-polarised T-cell function and biology in people with HIV under successful antiretroviral therapy and HIV elite controllers.

Plasma endocannabinoidome and fecal microbiota interplay in people with HIV and subclinical coronary artery disease: Results from the Canadian HIV and Aging Cohort Study.

Feasibility of a Randomized, Interventional Pilot Clinical Study of Oral Cannabinoids in People with HIV on Antiretroviral Therapy: CTNPT 028.

Dynamics of pulmonary mucosal cytotoxic CD8 T-cells in people living with HIV under suppressive antiretroviral therapy.

Efficient enzyme-free method to assess the development and maturation of the innate and adaptive immune systems in the mouse colon.

Correlates of Breakthrough SARS-CoV-2 Infections in People with HIV: Results from the CIHR CTN 328 Study.

Building Capacity in Innovative Adaptive Trial Designs for HIV and STBBI Research: The CTN-Québec Training Platform

Aging with HIV: understanding heterogeneity to promote health for all

Canadian HIV Cure Enterprise 3.0: Targeting tissue HIV reservoirs

Discovering pathways to successful aging in HIV infection

Canadian HIV Cure Enterprise 2.0: Targeting the interplay between myeloid cells and CD4+ T-cells for HIV cure

Discovering immune pathways to successful aging in HIV infection

Frequent collaborators

Mohammad-Ali Jenabian

Mohammad-Ali Jenabian

Jean-Pierre Routy

Jean-Pierre Routy

Petronela Ancuta

Nicolas Chomont

Nicolas Chomont

Shari Margolese

Madeleine Durand

Madeleine Durand

Ali Ahmad

Mark Hull

Marina Klein

Sharon Walmsley

Giada Sebastiani

Erwin Schurr

Devendra Amre

Mario Ostrowski

Cécile Tremblay

Vincenzo Di Marzo

Catharine Chambers

Sergio Rueda

Christos Tsoukas

Christos Tsoukas

Carl Chartrand-Lefebvre

Hasina Samji

Gordon Arbess

Hasina Samji

Kim Engler

Nicolas Flamand

Samer Mansour

Annie Bernier

Matthew Cheng

Danuta Radzioch

Ann Burchell

Nadine Kronfli

Darrell Tan

Zabrina Brumme

Larry Lands

Darrell Tan